These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 6085373

  • 1. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A, Lasaridis A, Settas L.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB, Bolli P, Erne P, Block LH, Kiowski W, Bühler FR.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [Abstract] [Full Text] [Related]

  • 3. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 4. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
    Esper RJ, Esper RC, Baglivo HP, Castro JM, Rohwedder RW, Menna J.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
    [Abstract] [Full Text] [Related]

  • 5. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME, Melin JA, Vanbutsele RJ, Lavenne F, Detry JM.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [Abstract] [Full Text] [Related]

  • 6. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E, Distler A, Gotzen R, Thiede HM, Philipp T.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [Abstract] [Full Text] [Related]

  • 7. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA, Glasser SP, Ram CV, McMahon SG, Vanov SK, Leibowitz DA.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C, Golub MS, Eggena P, Barrett JD, Sambhi MP.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [Abstract] [Full Text] [Related]

  • 10. Muzolimine and nitrendipine in the treatment of arterial hypertension.
    de Divitiis O, Di Somma S, Petitto M, Galderisi M, Iacono C, Fazio S.
    Z Kardiol; 1985; 74 Suppl 2():60-5. PubMed ID: 3159163
    [Abstract] [Full Text] [Related]

  • 11. Safety aspects of long-term nitrendipine therapy.
    Stoepel K, Deck K, Corsing C, Ingram C, Vanov SK.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1063-6. PubMed ID: 6085368
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H, Schmieder R, Langewitz W, Neus J, Wagner O, von Eiff AW.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [Abstract] [Full Text] [Related]

  • 13. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X, Gong L, Guo J, Wang X, Liu Y, Ye X, Zhang G, Yang P.
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW, Wiewel D.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [Abstract] [Full Text] [Related]

  • 15. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D, Burger KJ, Weidinger G.
    J Cardiovasc Pharmacol; 1990 Sep; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [Abstract] [Full Text] [Related]

  • 16. [Nitrendipine, a new calcium antagonist, in the therapy of arterial hypertension].
    Cosmi F, Mollaioli M, Aimi M, Conti G, Corbacelli C, Bianco C, Ricca M.
    Minerva Med; 1985 Nov 03; 76(42):1983-90. PubMed ID: 2933597
    [Abstract] [Full Text] [Related]

  • 17. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 03; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 18. Nitrendipine in hypertension that is difficult to control.
    Höffler D, Stoepel K.
    J Cardiovasc Pharmacol; 1984 Sep 03; 6 Suppl 7():S1060-2. PubMed ID: 6085367
    [Abstract] [Full Text] [Related]

  • 19. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O, Petitto M, Di Somma S, Galderisi M, Villari B, Santomauro M, Fazio S.
    Arzneimittelforschung; 1985 Sep 03; 35(4):727-9. PubMed ID: 3160356
    [Abstract] [Full Text] [Related]

  • 20. Amlodipine compared to nitrendipine for the treatment of mild-to-moderate hypertension.
    Englert R, Beressem P, von Manteuffel E, Stafunsky M, Kramar M.
    Postgrad Med J; 1991 Sep 03; 67 Suppl 5():S35-7. PubMed ID: 1839437
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.